Media Advisory
April 14, 2025
RESILIENCE: The International Conference on Multiple Chemical Sensitivity (MCS)
Canada’s leading MCS advocacy organizations, the Environmental Health Association of Canada and the Environmental Health Association of Québec, are hosting a groundbreaking two-day virtual event to spotlight MCS, amplify lived experiences, and mobilize action following the March 2025 UN CRPD Concluding Observations, which include MCS.
When:
May 1–2, 2025
Live online sessions daily from 9:00 a.m. to 5:00 p.m. EDT
Where:
Virtual – registration details
Why it matters:
- Multiple Chemical Sensitivity (MCS): over 1.13 million Canadians are diagnosed with MCS, this condition affects millions globally and remains widely misunderstood, under-recognized, and under-protected.
- The United Nations Committee on the Rights of Persons with Disabilities calls out Canada for the disproportionate discrimination and stigma experienced by the MCS Community
- The conference theme, Resilience, highlights the need to advance scientific understanding, foster collaborative research, and drive systemic change for a safer global environment and improved quality of life for people with MCS.
- This conference brings together experts, advocates, people with lived experience, medical professionals, and policymakers to chart a path forward.
Key Features:
- Presentations on the UN Concluding Observations
- First-hand testimonies from those living with MCS
- International collaboration: speakers from Canada, Europe, and Japan
- The launch of the national “Right to Breathe” advocacy campaign promoting fragrance-free healthcare in Canada
Who should attend:
- Journalists covering health, human rights, disability, housing, and environment
- Policy and healthcare professionals
- Advocates and community organizations
Speakers : A speakers list can be viewed here.
Agenda : An agenda for both days can be viewed at:
Partners : Partners can be viewed at the end of this page.
Contact :
Michel Gaudet, Executive Director – michelgaudet@aseq-ehaq.ca / 514 332 4320
-30-